S - Trademark Details
Status: 606 - Abandoned - No Statement Of Use Filed
Serial Number
74187128
Word Mark
S
Status
606 - Abandoned - No Statement Of Use Filed
Status Date
1993-07-29
Filing Date
1991-07-22
Mark Drawing
3S13 - Illustration: Drawing or design which also includes word(s)/ letter(s)/number(s)
75% Reduction
Design Searches
261302 - Plain single or multiple line quadrilaterals.
Published for Opposition Date
1992-05-05
Attorney Name
Law Office Assigned Location Code
G30
Employee Name
WISEMAN, MICHELLE S
Statements
Goods and Services
pharmaceuticals; namely, protein-based and other pharmaceuticals for use in treating diseases including inflammatory diseases, chronic skin ulcers, neurological disorders, rheumatoid arthritis, sepsis and septic shock, leukemia, cystic fibrosis, genetic emphysema, and peripheral neuropathies
Pseudo Mark
S
Classification Information
International Class
5 - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. - Pharmaceutical, veterinary and sanitary preparations; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes
018
Class Status Code
8 - Abandoned
Class Status Date
1999-08-04
Primary Code
005
Correspondences
Name
Jay H. Begler
Address
Please log in with your Justia account to see this address.
Trademark Events
| Event Date | Event Description |
| 1991-10-24 | ASSIGNED TO EXAMINER |
| 1991-11-05 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 1992-04-03 | NOTICE OF PUBLICATION |
| 1992-05-05 | PUBLISHED FOR OPPOSITION |
| 1992-07-28 | NOA MAILED - SOU REQUIRED FROM APPLICANT |
| 1993-01-12 | EXTENSION 1 FILED |
| 1993-02-17 | EXTENSION 1 GRANTED |
| 1993-07-29 | ABANDONMENT - NO USE STATEMENT FILED |
